We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCCO icon
176
Southern Copper
SCCO
$141B
$19.8M 0.13%
308,404
-50,484
-14% -$2.92M
ISEE
177
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$19.7M 0.13%
1,215,272
+539,697
+80% +$5.87M
RHI icon
178
Robert Half
RHI
$4.07B
$19.7M 0.13%
195,870
+139,743
+249% +$13.7M
HPQ icon
179
HP
HPQ
$24.3B
$19.6M 0.13%
715,919
+56,769
+9% +$1.63M
INVH icon
180
Invitation Homes
INVH
$17.6B
$19.6M 0.13%
510,405
+484,621
+1,880% +$19.4M
ALGN icon
181
Align Technology
ALGN
$12B
$19.5M 0.13%
29,356
-189
-0.6% -$128K
KMI icon
182
Kinder Morgan
KMI
$70.6B
$19.2M 0.13%
1,150,421
+70,653
+7% +$1.2M
MRSN
183
DELISTED
Mersana Therapeutics
MRSN
$19.1M 0.13%
80,916
+2,000
+3% +$584K
XLNX
184
DELISTED
Xilinx Inc
XLNX
$18.8M 0.13%
124,372
– –
BMO icon
185
Bank of Montreal
BMO
$125B
$18.7M 0.13%
187,726
-899
-0.5% -$90.5K
BBY icon
186
Best Buy
BBY
$18.6B
$18.7M 0.13%
177,063
-51,892
-23% -$5.83M
CYTK icon
187
Cytokinetics
CYTK
$10.9B
$18.3M 0.12%
513,344
– –
MGLN
188
DELISTED
Magellan Health Services, Inc.
MGLN
$18.3M 0.12%
193,817
– –
SLB icon
189
SLB Ltd
SLB
$76.5B
$18.2M 0.12%
613,000
+101,225
+20% +$2.9M
ITCI
190
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.1M 0.12%
485,466
+165,979
+52% +$5.77M
SWK icon
191
Stanley Black & Decker
SWK
$14.6B
$18.1M 0.12%
103,155
+95,996
+1,341% +$18.7M
RLAY icon
192
Relay Therapeutics
RLAY
$4.06B
$17.7M 0.12%
562,938
– –
KURA icon
193
Kura Oncology
KURA
$901M
$17.7M 0.12%
946,357
– –
FRTA
194
DELISTED
Forterra, Inc
FRTA
$17.3M 0.12%
734,897
– –
UFS
195
DELISTED
DOMTAR CORPORATION (New)
UFS
$17.2M 0.12%
315,996
– –
KLAC icon
196
KLA
KLAC
$266B
$17M 0.12%
507,740
+71,000
+16% +$2.37M
UPS icon
197
United Parcel Service
UPS
$96B
$16.9M 0.12%
92,953
-98,728
-52% -$19.5M
CTMX icon
198
CytomX Therapeutics
CTMX
$708M
$16.8M 0.11%
3,305,940
+977,587
+42% +$5.23M
LRCX icon
199
Lam Research
LRCX
$365B
$16.8M 0.11%
294,900
-163,940
-36% -$9.97M
NRIX icon
200
Nurix Therapeutics
NRIX
$2.43B
$16.6M 0.11%
554,996
+47,693
+9% +$1.47M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.